Listed

Standard Biotools Inc.

LABNasdaqCIK 1162194HealthcareFiscal year ends Dec 31

Reports and events: 345 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Standard Biotools Inc., Reports and events
FiledFormWhat it isAccession number
2022-11-0816:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-22-007235
2022-08-0916:28 ET10-QQuarterly reportPeriod 2022-06-300001162194-22-000091
2022-08-0816:23 ET8-K2.02 Results of operations; 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits0001171843-22-005465
2022-08-0511:13 ETSC 13D/AOwnership report, active investor, amended0000902664-22-003824
2022-08-0317:14 ET8-K5.02 Departure or appointment of officers or directors0001162194-22-000088
2022-07-0716:00 ET8-K5.02 Departure or appointment of officers or directors0001162194-22-000086
2022-06-2716:04 ET8-K5.02 Departure or appointment of officers or directors0001162194-22-000084
2022-06-1614:06 ET8-K5.07 Shareholder vote results0001162194-22-000067
2022-06-0710:31 ETSC 13D/AOwnership report, active investor, amended0000902664-22-003184
2022-05-0914:21 ET10-QQuarterly reportPeriod 2022-03-310001162194-22-000055
2022-05-0516:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-22-003333
2022-05-0312:40 ETSC 13D/AOwnership report, active investor, amended0000902664-22-002749
2022-04-2917:23 ETDEF 14AProxy statementPeriod 2022-06-150001162194-22-000050
2022-04-0817:07 ETSC 13DOwnership report, active investor0000950142-22-001358
2022-04-0517:07 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-096290
2022-03-2917:14 ETSC 13D/AOwnership report, active investor, amended0000902664-22-002331
2022-03-2909:35 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-22-087550
2022-03-2806:10 ET8-K1.01 Entry into a material agreement; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-085854
2022-03-1616:05 ET8-K5.02 Departure or appointment of officers or directors0001162194-22-000022
2022-03-0819:05 ET10-KAnnual reportPeriod 2021-12-310001162194-22-000021
2022-02-2416:45 ETDEF 14AProxy statementPeriod 2022-03-250001193125-22-052230
2022-02-1818:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-22-001154
2022-02-1116:06 ET8-K/A9.01 Financial statements and exhibits0001193125-22-036985
2022-01-2417:24 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-016151
2022-01-1108:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-22-000217
2021-11-1817:28 ETSC 13DOwnership report, active investor0001567619-21-020773
2021-11-0920:23 ET10-QQuarterly reportPeriod 2021-09-300001162194-21-000087
2021-11-0816:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-21-007684
2021-09-0716:53 ET8-K2.03 New direct financial obligation0001193125-21-266704
2021-08-0616:24 ET10-QQuarterly reportPeriod 2021-06-300001162194-21-000072
2021-08-0516:22 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-21-005580
2021-08-0516:11 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001162194-21-000070
2021-05-2517:10 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001162194-21-000048
2021-05-1017:20 ETSC 13DOwnership report, active investor0000902664-21-002673
2021-05-0717:30 ET10-QQuarterly reportPeriod 2021-03-310001628280-21-009552
2021-05-0616:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-21-003265
2021-04-2916:56 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001162194-21-000034
2021-04-1417:14 ETDEF 14AProxy statementPeriod 2021-05-250001162194-21-000020
2021-02-2514:21 ET10-KAnnual reportPeriod 2020-12-310001162194-21-000013
2021-02-1016:08 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-21-000919
2020-12-1516:50 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001162194-20-000118
2020-11-0918:30 ET10-QQuarterly reportPeriod 2020-09-300001162194-20-000107
2020-11-0516:12 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-20-007675
2020-09-2918:11 ET8-K1.01 Entry into a material agreement0001162194-20-000106
2020-09-0806:10 ET8-K8.01 Other events0001171843-20-006298
2020-08-0716:28 ET10-QQuarterly reportPeriod 2020-06-300001162194-20-000093
2020-08-0616:08 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-20-005661
2020-06-2416:58 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001162194-20-000076
2020-05-1416:54 ETDEF 14AProxy statementPeriod 2020-06-230001162194-20-000046
2020-05-1115:06 ET10-QQuarterly reportPeriod 2020-03-310001162194-20-000042

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 5, 2026, 21:16 ET. Listed shows no prices and gives no investment advice.